ATE322912T1 - Radiomarkierte pyrimidinnukleoside zur diagnose von gewebe-reproduzierender aktivität - Google Patents
Radiomarkierte pyrimidinnukleoside zur diagnose von gewebe-reproduzierender aktivitätInfo
- Publication number
- ATE322912T1 ATE322912T1 AT02716326T AT02716326T ATE322912T1 AT E322912 T1 ATE322912 T1 AT E322912T1 AT 02716326 T AT02716326 T AT 02716326T AT 02716326 T AT02716326 T AT 02716326T AT E322912 T1 ATE322912 T1 AT E322912T1
- Authority
- AT
- Austria
- Prior art keywords
- denotes
- radiom
- substituent
- pyrimidine nucleosides
- denotes hydrogen
- Prior art date
Links
- 239000002718 pyrimidine nucleoside Substances 0.000 title 1
- 230000001850 reproductive effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001014954 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE322912T1 true ATE322912T1 (de) | 2006-04-15 |
Family
ID=18881578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02716326T ATE322912T1 (de) | 2001-01-23 | 2002-01-22 | Radiomarkierte pyrimidinnukleoside zur diagnose von gewebe-reproduzierender aktivität |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7045115B2 (de) |
| EP (1) | EP1270017B1 (de) |
| JP (1) | JP4210118B2 (de) |
| KR (1) | KR100867729B1 (de) |
| CN (1) | CN100400107C (de) |
| AT (1) | ATE322912T1 (de) |
| AU (1) | AU2002226690B2 (de) |
| CA (1) | CA2402991C (de) |
| DE (1) | DE60210538T2 (de) |
| NO (1) | NO328812B1 (de) |
| NZ (1) | NZ520934A (de) |
| TW (1) | TWI247609B (de) |
| WO (1) | WO2002058740A1 (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| WO2005026131A1 (en) * | 2003-09-05 | 2005-03-24 | Albert Einstein College Of Medicine Of Yeshiva University | Transition state structure and inhibitors of thymidine phosphorylases |
| JP5379347B2 (ja) * | 2003-09-18 | 2013-12-25 | アイシス ファーマシューティカルズ， インコーポレーテッド | ４’−チオヌクレオシドおよびオリゴマー化合物 |
| US7485283B2 (en) * | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
| JP4841231B2 (ja) * | 2005-11-07 | 2011-12-21 | 日本メジフィジックス株式会社 | 組織増殖能診断用薬剤 |
| CA2649182C (en) * | 2006-04-07 | 2018-01-02 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to adenoassociated virus-phage particles |
| WO2008109080A2 (en) * | 2007-03-01 | 2008-09-12 | Siemens Medical Solutions Usa, Inc. | Nucleoside based proliferation imaging markers |
| EP2155231B1 (de) * | 2007-04-10 | 2012-08-08 | The Johns Hopkins University | Bilddarstellung und behandlung von virus-assoziierten tumoren |
| WO2009110984A2 (en) * | 2008-02-29 | 2009-09-11 | Lantheus Medical Imaging, Inc. | Contrast agents for applications including perfusion imaging |
| GB0815831D0 (en) * | 2008-09-01 | 2008-10-08 | Imp Innovations Ltd | Compounds |
| ES2770364T3 (es) | 2009-04-15 | 2020-07-01 | Lantheus Medical Imaging Inc | Estabilización de composiciones radiofarmacéuticas utilizando ácido ascórbico |
| RU2631500C2 (ru) | 2010-02-08 | 2017-09-25 | Лантеус Медикал Имаджинг, Инк. | Способы и устройство для синтезирования радиофармацевтических препаратов и их промежуточных продуктов |
| WO2012048331A2 (en) * | 2010-10-09 | 2012-04-12 | Phynexus, Inc. | Isolation of phosphoproteins, glycoproteins and fragments thereof |
| JP5794521B2 (ja) * | 2011-03-29 | 2015-10-14 | 国立大学法人福井大学 | アポトーシス誘導剤 |
| SG10201603288XA (en) | 2012-03-28 | 2016-05-30 | Fujifilm Corp | Salt Of 1-(2-Deoxy-2-Fluoro-4-Thio-beta-D-Arabinofuranosyl)Cytosine |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| KR20170001722A (ko) * | 2012-08-13 | 2017-01-04 | 후지필름 가부시키가이샤 | 1-(2-데옥시-2-플루오로-4-티오-β-D-아라비노푸라노실)시토신의 합성 중간체, 티오뉴클레오시드의 합성 중간체, 및 그들의 제조법 |
| JP2014062054A (ja) * | 2012-09-20 | 2014-04-10 | Gyoseiin Genshino Iinkai Kakuno Kenkyusho | よう素−１２３標記チミン類似物［１２３Ｉ］−ＩａｒａＵのプローブ |
| JP6351107B2 (ja) * | 2014-02-18 | 2018-07-04 | 富士フイルム株式会社 | チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物 |
| TWI678373B (zh) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | 硫代核苷衍生物或其鹽及醫藥組合物 |
| BR112019003946A2 (pt) | 2016-08-31 | 2019-05-21 | Fujifilm Corporation | agente antitumoral, reforçador do efeito antitumoral e kit antitumoral |
| MX2018002611A (es) | 2018-01-29 | 2019-07-30 | Fujifilm Corp | Agente antitumoral para cancer del tracto biliar y metodo para tratar cancer del tracto biliar. |
| CN113683648B (zh) * | 2021-08-26 | 2025-03-07 | 上海皓鸿生物医药科技有限公司 | 一种2’-氟-2’-脱氧尿苷的合成方法及其中间体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| US5077034A (en) | 1990-03-30 | 1991-12-31 | The President And Fellows Of Harvard College | Treatment of tumors with 5-radioiodo-2'-deoxyuridine |
| US5248771A (en) | 1991-06-26 | 1993-09-28 | Triumf | Process for preparing no-carrier-added radiohalogenated vinyl nucleosides |
| GB9421223D0 (en) | 1994-10-21 | 1994-12-07 | Univ Alberta | Tissue imaging in gene therapy |
| US5574148A (en) | 1995-02-02 | 1996-11-12 | President U Fellows Of Harvard College | Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides |
| US5703056A (en) | 1995-03-15 | 1997-12-30 | Sloan-Kettering Institute For Cancer Research | Non-invasive imaging of gene transfer |
| US5720935A (en) * | 1995-06-09 | 1998-02-24 | President & Fellows Of Harvard College | Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides from stannyl precursors |
| AU5774796A (en) | 1995-06-13 | 1997-01-09 | Dyer, Alison Margaret | Pharmaceutical compositions containing lornoxicam and cyclod extrin |
| US6331287B1 (en) | 1995-08-23 | 2001-12-18 | University Advanced Bio-Imaging Associates | 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside |
| WO2001005439A1 (en) * | 1999-07-14 | 2001-01-25 | President And Fellows Of Harvard College | Radiodetection and therapy of aberrant cell proliferation |
| KR200188038Y1 (ko) | 2000-01-24 | 2000-07-15 | 이정진 | 전자파 피해가 감소되는 안테나 구조를 가진 휴대폰. |
-
2002
- 2002-01-18 TW TW091100830A patent/TWI247609B/zh not_active IP Right Cessation
- 2002-01-22 DE DE60210538T patent/DE60210538T2/de not_active Expired - Lifetime
- 2002-01-22 NZ NZ52093402A patent/NZ520934A/xx not_active IP Right Cessation
- 2002-01-22 WO PCT/JP2002/000408 patent/WO2002058740A1/ja not_active Ceased
- 2002-01-22 AT AT02716326T patent/ATE322912T1/de not_active IP Right Cessation
- 2002-01-22 US US10/239,355 patent/US7045115B2/en not_active Expired - Lifetime
- 2002-01-22 CA CA002402991A patent/CA2402991C/en not_active Expired - Fee Related
- 2002-01-22 CN CNB028001540A patent/CN100400107C/zh not_active Expired - Fee Related
- 2002-01-22 KR KR1020027012275A patent/KR100867729B1/ko not_active Expired - Fee Related
- 2002-01-22 AU AU2002226690A patent/AU2002226690B2/en not_active Ceased
- 2002-01-22 JP JP2002559074A patent/JP4210118B2/ja not_active Expired - Lifetime
- 2002-01-22 EP EP02716326A patent/EP1270017B1/de not_active Expired - Lifetime
- 2002-09-10 NO NO20024324A patent/NO328812B1/no not_active IP Right Cessation
-
2004
- 2004-11-16 US US10/988,657 patent/US7118731B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US20050129611A1 (en) | 2005-06-16 |
| NO328812B1 (no) | 2010-05-18 |
| JPWO2002058740A1 (ja) | 2004-05-27 |
| US7045115B2 (en) | 2006-05-16 |
| EP1270017A1 (de) | 2003-01-02 |
| NZ520934A (en) | 2004-12-24 |
| NO20024324L (no) | 2002-11-07 |
| JP4210118B2 (ja) | 2009-01-14 |
| EP1270017B1 (de) | 2006-04-12 |
| DE60210538D1 (de) | 2006-05-24 |
| TWI247609B (en) | 2006-01-21 |
| AU2002226690B2 (en) | 2006-07-13 |
| KR100867729B1 (ko) | 2008-11-10 |
| NO20024324D0 (no) | 2002-09-10 |
| WO2002058740A1 (fr) | 2002-08-01 |
| US20030124054A1 (en) | 2003-07-03 |
| CA2402991A1 (en) | 2002-08-01 |
| KR20020084212A (ko) | 2002-11-04 |
| CN100400107C (zh) | 2008-07-09 |
| DE60210538T2 (de) | 2006-10-05 |
| US7118731B2 (en) | 2006-10-10 |
| CA2402991C (en) | 2009-06-23 |
| CN1455683A (zh) | 2003-11-12 |
| EP1270017A4 (de) | 2004-04-28 |
| HK1059396A1 (zh) | 2004-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60210538D1 (de) | Radiomarkierte pyrimidinnukleoside zur diagnose von gewebe-reproduzierender aktivität | |
| PE20030601A1 (es) | Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y transtornos relacionados | |
| RU2009143333A (ru) | Производные аминодигидротиазина, замещенные циклической группой | |
| DE602005024279D1 (de) | 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren | |
| ID27531A (id) | Penggunaan senyawa untuk peningkatan aktivitas piruvat dehidrogenase | |
| ATE471323T1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| GB0021831D0 (en) | Chemical compounds | |
| DE69626218D1 (de) | 4-pyrimidinyl- or 4-pyrazinyl-piperazinyl-phenyl-oxazolidinon derivate, deren herstellung und deren verwendung als antibakterielle mittel | |
| BR0002796A (pt) | Compostos de 2-benzimidazolilamina como agonistas de receptores orl1 | |
| NO933452L (no) | Et terapeutisk middel for Parkinson's sykdom | |
| BRPI0507180A (pt) | derivados de 1-isopropil-2-oxo-1,2-diidropiridina-3-carboxamida tendo atividade agonìstica de receptor 5-ht4 | |
| EA200100204A1 (ru) | Фармацевтические агенты для лечения болезни паркинсона, ганв и микроаденом | |
| DE69914478D1 (de) | Oxazolidinon-derivate als antibiotika, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen | |
| DE60003220D1 (de) | [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDIN-DERIVATE ALS ANTITHROMBOTISCHE MITTEL | |
| DK283487D0 (da) | Thiazolyl-2-yl-imidazo(1,2-a)pyrimidiner, deres fremstilling og brug | |
| ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
| DK0626367T3 (da) | (7S)-7- (2R)-2-(3-chlorphenyl)-2-hydroxyethylamino -5,6,7,8-tetrahydronapthalen-2-yloxyeddikesyre og farmaceutisk acceptable salte deraf med beta3-adrenerg agonistvirkning, farmaceutiske præparater og laboratoriereagenser som indeholder den. | |
| RU2008122401A (ru) | Новые n-(фтор-пиразинил)-фенилсульфонамиды в качестве модуляторов хемокинового рецептора ccr4 | |
| DE60031699D1 (de) | Hydroxyacetamidobenzolsulfonamidderivate | |
| DE69919478D1 (de) | 7-Aminopyrido(2,3-d)-pyrimidine Derivate zur Behandlung von Bronchialasthma | |
| EA200400877A1 (ru) | 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи | |
| ATE278701T1 (de) | Malto-oligosaccharide und deren verwendung | |
| ES504259A0 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina | |
| AU2002222225A1 (en) | Substituted-4-quinolones | |
| BR112021012834A2 (pt) | Derivados de pirimidina para a prevenção e tratamento de infecções bacterianas gram-negativas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |